2025 third_quarter Filing
Q3Income
$40K
Filed
October 20, 2025
Lobbying Activities
Health IssuesView all
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); and H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); FY2026 appropriations language related to substance use prevention and treatment
Contacted:HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (4)
mrs DANA SCHNEEBERGER WOOD
SCOTT MCGEE
LAURIE RUBINER
MAGGIE CLARKE CROSSWY